Paenibacillus strain, antifungal compounds, and methods for their use

US11623944B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11623944-B2
Application numberUS-201916669783-A
CountryUS
Kind codeB2
Filing dateOct 31, 2019
Priority dateMar 26, 2015
Publication dateApr 11, 2023
Grant dateApr 11, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain comprising a variant fusaricidin synthetase lacking a functional adenylation domain in the third module. The present invention also provides a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain or a cell-free extract thereof comprising at least one Paeniserine and at least one Paeniprolixin. Also provided are isolated compounds and methods of treating a plant to control a plant disease with the disclosed compositions and compounds.

First claim

Opening claim text (preview).

We claim: 1. A composition comprising a compound having the structure wherein (a) R 1 is —CH 2 OH; R 2 is —CH 2 C(O)NH 2 ; and R 3 is H; (b) R 1 is —CH 2 OH; R 2 is —(CH 2 ) 2 C(O)NH 2 ; and R 3 is H; (c) R 1 is —CH 2 OH; R 2 is —(CH 2 ) 2 C(O)NH 2 ; and R 3 is CH 3 , (d) R 1 is —CH(OH)CH 3 ; R 2 is —CH 2 C(O)NH 2 ; and R 3 is H; or (e) R 1 is —CH(OH)CH 3 ; R 2 is —(CH 2 ) 2 C(O)NH 2 ; and R 3 is H including salts, hydrates, solvates, polymorphs, optical isomers, geometrical isomers, enantiomers, diastereomers and mixtures thereof. 2. The composition according to claim 1 , wherein the compound having the structure (II) is 3. The composition of claim 1 , wherein the composition is a fermentation product of a Paenibacillus sp. strain. 4. The composition of claim 3 , wherein the Paenibacillus sp. strain comprises a variant fusaricidin synthetase lacking a functional adenylation domain in the third module (FusA-A3), and wherein the lack of a functional FusA-A3 inhibits synthesis of fusaricidins with a tyrosine or a phenylalanine at amino acid residue (3) compared to synthesis of fusaricidins by a Paenibacillus sp. strain comprising a wild-type fusaricidin synthetase. 5. The composition of claim 3 , wherein the fermentation product further comprises a formulation ingredient selected from the group consisting of a wetting agent, extender, solvent, spontaneity promoter, dispersant, frost protectant, thickener and adjuvant. 6. The composition of claim 4 , wherein the variant fusaricidin synthetase comprises an amino acid sequence exhibiting at least 90% sequence identity to SEQ ID NO: 10. 7. The composition of claim 6 , wherein the Paenibacillus sp. strain is Paenibacillus sp. strain NRRL B-50972, Paenibacillus sp. strain NRRL B-67129, or a fungicidal mutant strain thereof. 8. The composition of claim 1 , further comprising a fusaricidin. 9. The composition of claim 8 , wherein the fusaricidin is fusaricidin A. 10. The composition of claim 9 , wherein the compound having the structure II is 11. The composition according to claim 8 , wherein the weight ratio of the fusaricidin and the compound having the structure (II) is in the range of 1:1000 to 1000:1. 12. A method of treating a plant to control a disease, wherein the method comprises applying an effective amount of the composition according to claim 1 to the plant, to a part of the plant and/or to a locus of the plant. 13. The method of claim 12 , wherein the method comprises applying the composition to foliar plant parts. 14. The method of claim 12 , wherein the disease is caused by a fungus selected from the group consisting of Alternaria alternata, Alternaria solani, Botrytis cinerea, Colletotrichum lagenarium, Fusarium culmorum, Phaeosphaeria nodorum, Zymoseptoria tritici, Phytophthora cryptogea, Phytophthora infestans, Pythium ultimum, Magnaporthe oryzae, Thanatephorus cucumeris, Ustilago segetum var. avenae, Uromyces appendiculatus , and Puccinia triticina. 15. The method of claim 12 , wherein the disease is a mildew or a rust disease selected from the group consisting of powdery mildew, downy mildew, wheat leaf rust, leaf rust of barley, leaf rust of rye, brown leaf rust, crown rust, and stem rust. 16. The method of claim 12 , wherein the disease is caused by bacteria selected from the group consisting of Xanthomonas campestris, Pseudomonas syringae , and Erwinia carotovora.

Assignees

Inventors

Classifications

  • from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia · CPC title

  • Isomerases (5.) · CPC title

  • Cyclic peptides containing at least one abnormal peptide link · CPC title

  • having 5 to 11 amino acids · CPC title

  • A01N63/25Primary

    Paenibacillus · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11623944B2 cover?
The present invention relates to a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain comprising a variant fusaricidin synthetase lacking a functional adenylation domain in the third module. The present invention also provides a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain or a cell-free extract thereof …
Who is the assignee on this patent?
Bayer Cropscience Lp
What technology area does this patent fall under?
Primary CPC classification A01N63/25. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).